Discontinued Investigational Programs
As a member of the Pharmaceutical Research and Manufacturers of America (PhRMA), Bristol-Myers Squibb is committed to increasing its transparency of clinical trial results. To demonstrate our commitment, Bristol-Myers Squibb will voluntarily disclose the results from investigational products whose development programs have been discontinued after October 1, 2009, regardless of outcome. We commit to reporting this information in a timely manner by disclosing materials which will summarize the results.
Discontinued Investigational Program Details